The issue of incidental data, which has always existed in genetics, is becoming exponential with the advent of genomic medicine. The issue of secondary data, involving an active search for variants in a list of so-called actionable genes, is very popular in the USA, whereas Europeans are urging caution.
In this webinar, we would like to take a look at the evolution of recommendations made by certain European countries, as well as those of the ESHG.
Program:
Welcome and Introduction
Speaker : Laurence Faivre
From : CHU Dijon-Bourgogne, Dijon, France
ESHG recommendations on Opportunistic genomic screening
Speaker : Dr Francesca Forzano
From : King’s College, London, UK
Secondary findings in exome sequencing. Experience in a tertiary public hospital in Spain
Speaker : Dr Marta Codina Solà and Dr Anna Abuli
From : Hospital Universitari Vall d’Hebron, Barcelona, Spain
Management of unexpected findings in the NHS England Genomic Medicine Service
Speaker : Rachael Mein
From : NHS England Genomics Unit Senior Laboratory Advisor (Rare Disease), UK
Studies for exploring the expectations of patients/families regarding additional findings from exome sequencing in France
Speaker : Laurence Faivre
From : CHU Dijon-Bourgogne, Dijon, France
Date: 28 November, 05:00 – 06:30 PM, French time
Registration form: https://forms.office.com/e/cUU3JXMYTt
Link to connect: Rejoindre la conversation (microsoft.com)Rejoindre la conversation (microsoft.com)